chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/12, Pfizer, dose #1 02/03, Pfizer, dose #2 09/23, Pfizer, dose #3 12/21 COVID swab, result: detected 12/21 pt cc: fatigue, sore throat, exposure: unknown
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Oropharyngeal pain, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 08/12, Pfizer, dose #1 09/02, Pfizer, dose #2 12/20 SARS-COV-2 Variant Sequencing: pending 12/20 COVID swab, result: detected 12/20 pt cc: sore throat exposure: unknown 12/20 CXR impression: no acute cardiopulmonary disease. 01/04/22 CXR Impression: No acute cardiopulmonary process.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Fatigue, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/07, dose #2 12/22 CXR impression: No acute cardiopulmonary process.  12/22 COVID swab, result: detected 12/22 pt admitted to ED cc: sore throat dx: COVID-19 LOS: 1 day 12/19 pt cc: cough, rhinorrhea, sore throat, fatigue, exposure: unknown 12/22 SARS-COV-2 Variant Sequencing: pending 12/28 clinically resolved
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/07, dose #2 12/22 CXR impression: No acute cardiopulmonary process.  12/22 COVID swab, result: detected 12/22 pt admitted to ED cc: sore throat dx: COVID-19 LOS: 1 day 12/19 pt cc: cough, rhinorrhea, sore throat, fatigue, exposure: unknown 12/22 SARS-COV-2 Variant Sequencing: pending 12/28 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Condition aggravated
Clinical narrative: Narrative: Admission Date: Jan 1,2022 Discharge Date: Jan 4,2022 Primary Diagnosis during Admission/Treatment: Acute on chronic hypoxic respiratory failure secondary to COVID Pneumonia 74 y.o male w/ past medical history of COPD, HTN, OSA, CAD s/p 2V CABG (1997) PCI to LAD 2011, HFrEF (LVEF 37% 3/2020), ICD placement in 2011, and atrial flutter presented to the Emergency Dept with SOB. Patient reported he has been experiencing DOE for last few months but recently began using his home O2 chronically instead of PRN. In the two days prior to coming to the D, he reported having to uptitrate his O2 requirement from 3L to 3.5-4 LPM. CXR obtained in ED was of poor quality but showed hazy opacity in left mid to lower lung opacities. He was admitted for acute on chronic hypoxic respiratory failure. Antibiotics held in favor of primary COVID Pneumonia infection. Started Remdesivir and Dexamethasome per COVID-19 protocol. Oxygen titrated during admission to patient's baseline 3-4 LPM. Underwent walk test 1/4/22 and satted at 95% on 4L after ambulating in the room, which he said was at his baseline. Discharged In stable condition. His immunization dates were the following: Date Immunization Series 04/08/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 2 03/17/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 1
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Lung opacity, Pneumonia, Pulmonary oedema
Clinical narrative: Narrative: Admission Date: Jan 1,2022 Discharge Date: Jan 4,2022 Primary Diagnosis during Admission/Treatment: Acute on chronic hypoxic respiratory failure secondary to COVID Pneumonia 74 y.o male w/ past medical history of COPD, HTN, OSA, CAD s/p 2V CABG (1997) PCI to LAD 2011, HFrEF (LVEF 37% 3/2020), ICD placement in 2011, and atrial flutter presented to the Emergency Dept with SOB. Patient reported he has been experiencing DOE for last few months but recently began using his home O2 chronically instead of PRN. In the two days prior to coming to the D, he reported having to uptitrate his O2 requirement from 3L to 3.5-4 LPM. CXR obtained in ED was of poor quality but showed hazy opacity in left mid to lower lung opacities. He was admitted for acute on chronic hypoxic respiratory failure. Antibiotics held in favor of primary COVID Pneumonia infection. Started Remdesivir and Dexamethasome per COVID-19 protocol. Oxygen titrated during admission to patient's baseline 3-4 LPM. Underwent walk test 1/4/22 and satted at 95% on 4L after ambulating in the room, which he said was at his baseline. Discharged In stable condition. His immunization dates were the following: Date Immunization Series 04/08/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 2 03/17/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 1
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Spinal osteoarthritis, Walking distance test
Clinical narrative: Narrative: Admission Date: Jan 1,2022 Discharge Date: Jan 4,2022 Primary Diagnosis during Admission/Treatment: Acute on chronic hypoxic respiratory failure secondary to COVID Pneumonia 74 y.o male w/ past medical history of COPD, HTN, OSA, CAD s/p 2V CABG (1997) PCI to LAD 2011, HFrEF (LVEF 37% 3/2020), ICD placement in 2011, and atrial flutter presented to the Emergency Dept with SOB. Patient reported he has been experiencing DOE for last few months but recently began using his home O2 chronically instead of PRN. In the two days prior to coming to the D, he reported having to uptitrate his O2 requirement from 3L to 3.5-4 LPM. CXR obtained in ED was of poor quality but showed hazy opacity in left mid to lower lung opacities. He was admitted for acute on chronic hypoxic respiratory failure. Antibiotics held in favor of primary COVID Pneumonia infection. Started Remdesivir and Dexamethasome per COVID-19 protocol. Oxygen titrated during admission to patient's baseline 3-4 LPM. Underwent walk test 1/4/22 and satted at 95% on 4L after ambulating in the room, which he said was at his baseline. Discharged In stable condition. His immunization dates were the following: Date Immunization Series 04/08/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 2 03/17/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 1
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Enterovirus test positive, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/21, MODERNA, dose #1 06/18, MODERNA, dose #2 12/20 HUMAN RHINOVIRUS/ENTEROVIRUS: DETECTED 12/20 SARS-COV-2 Variant Sequencing: pending 12/27 COVID swab, result: detected 12/17 pt cc: cough, diarrhea, fatigue, headache, rhinorrhea, sore throat exposure: unknown
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Human rhinovirus test positive, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/21, MODERNA, dose #1 06/18, MODERNA, dose #2 12/20 HUMAN RHINOVIRUS/ENTEROVIRUS: DETECTED 12/20 SARS-COV-2 Variant Sequencing: pending 12/27 COVID swab, result: detected 12/17 pt cc: cough, diarrhea, fatigue, headache, rhinorrhea, sore throat exposure: unknown
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 Private sector 03/04, Pfizer, dose #2 Private sector 10/29 COVID swab, result: not detected 12/22 COVID swab, result: detected 12/20 pt cc: fatigue, rhinorrhea, sore throat exposure: unknown 12/22 SARS-COV-2 Variant Sequencing: pending
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 Private sector 03/04, Pfizer, dose #2 Private sector 10/29 COVID swab, result: not detected 12/22 COVID swab, result: detected 12/20 pt cc: fatigue, rhinorrhea, sore throat exposure: unknown 12/22 SARS-COV-2 Variant Sequencing: pending
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Fatigue
Clinical narrative: Narrative:  COID infection following COVID vaccine series 08/04, Pfizer, dose #1 09/08, Pfizer dose #2 12/21 COVID swab, result: detected 12/17 pt cc: cough, fatigue, loss of taste or smell, myalgia, rhinorrhea, sore throat exposure: unknown
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COID infection following COVID vaccine series 08/04, Pfizer, dose #1 09/08, Pfizer dose #2 12/21 COVID swab, result: detected 12/17 pt cc: cough, fatigue, loss of taste or smell, myalgia, rhinorrhea, sore throat exposure: unknown
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/27, Pfizer, dose #2 09/20 COVID swab, result: detected 09/21 COVID-19 ANTIGEN (BINAX): NOT DETECTED 12/22 SARS-COV-2 Variant Sequencing: pending 12/22 COVID swab, result: detected 12/29 pt cc: congestion, cough, Rhinorrhea, exposure: unknown
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/27, Pfizer, dose #2 09/20 COVID swab, result: detected 09/21 COVID-19 ANTIGEN (BINAX): NOT DETECTED 12/22 SARS-COV-2 Variant Sequencing: pending 12/22 COVID swab, result: detected 12/29 pt cc: congestion, cough, Rhinorrhea, exposure: unknown
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chills, Cough, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/08, Pfizer dose #2 08/31, Pfizer, dose #2 12/21 COVID swab, result: detected 12/20 pt cc: cough, rhinorrhea, chills, fatigue, myalgias, rhinorrhea, sore throat exposure: co-worker 12/30 clinically resolved
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/08, Pfizer dose #2 08/31, Pfizer, dose #2 12/21 COVID swab, result: detected 12/20 pt cc: cough, rhinorrhea, chills, fatigue, myalgias, rhinorrhea, sore throat exposure: co-worker 12/30 clinically resolved
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/21 CXR impression: Mild bibasilar densities probably atelectasis. No definite pneumonia or pulmonary edema. Viral pneumonia may not be detected by chest radiograph. 12/21 SARS-COV-2 Variant Sequencing: pending 12/21 COVID swab, result: detected 12/29 COVID swab, result: detected 11/27 pt cc: flu-like symptoms, chest wall pain, nausea, headache, fever, chills, myalgias, cough, weakness exposure: unknown 11/30 pt admit to ED dx: COVID PNA LOS: 1
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Influenza like illness, Musculoskeletal chest pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/21 CXR impression: Mild bibasilar densities probably atelectasis. No definite pneumonia or pulmonary edema. Viral pneumonia may not be detected by chest radiograph. 12/21 SARS-COV-2 Variant Sequencing: pending 12/21 COVID swab, result: detected 12/29 COVID swab, result: detected 11/27 pt cc: flu-like symptoms, chest wall pain, nausea, headache, fever, chills, myalgias, cough, weakness exposure: unknown 11/30 pt admit to ED dx: COVID PNA LOS: 1
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/21 CXR impression: Mild bibasilar densities probably atelectasis. No definite pneumonia or pulmonary edema. Viral pneumonia may not be detected by chest radiograph. 12/21 SARS-COV-2 Variant Sequencing: pending 12/21 COVID swab, result: detected 12/29 COVID swab, result: detected 11/27 pt cc: flu-like symptoms, chest wall pain, nausea, headache, fever, chills, myalgias, cough, weakness exposure: unknown 11/30 pt admit to ED dx: COVID PNA LOS: 1
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 101.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 07/27, Pfizer, dose #1 08/17, Pfizer, dose #2 12/16 pt cc: fever, sore throat exposure: unknown 12/20 SARS-COV-2 Variant Sequencing: pending 12/20COVID swab, result: detected 12/28 COVID swab, result: detected
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/05, MODERNA, dose #1 04/30, MODERNA, dose #2 12/20 SARS-COV-2 Variant Sequencing: pending 12/20 COVID swab, result: detected 12/20 pt cc: chills, cough, fatigue, headaches, myalgias, rhinorrhea, exposure: unknown
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/05, MODERNA, dose #1 04/30, MODERNA, dose #2 12/20 SARS-COV-2 Variant Sequencing: pending 12/20 COVID swab, result: detected 12/20 pt cc: chills, cough, fatigue, headaches, myalgias, rhinorrhea, exposure: unknown
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/08, Pfizer, dose #2 09/02, Pfizer, dose #3 12/21 COVID swab, result: detected 12/21 SARS-COV-2 Variant Sequencing: pending 12/16 pt cc: cough, rhinorrhea, sore throat, exposure: wife 12/26 clinically resolved
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/08, Pfizer, dose #2 09/02, Pfizer, dose #3 12/21 COVID swab, result: detected 12/21 SARS-COV-2 Variant Sequencing: pending 12/16 pt cc: cough, rhinorrhea, sore throat, exposure: wife 12/26 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Chest discomfort, Chills, Death, Feeling abnormal
Clinical narrative: Narrative:  Patient received an additional booster (she reports 4th dose, Pfizer, however this, nor the alluded to 3rd dose, was not received at agency MC) on 12/29/21. That evening, he began to feel poorly and they noted tachycardia, hypertension, fevers, and chills. This prompted a call to the agency nurses line which is documented 12/30/21. Unfortunately, during that call, his wife reports that he had a "seizure" and lost consciousness. She called EMS at that time, and states she performed some chest compressions as the paramedics were on their way. Patient was pulseless upon their arrival and declared dead at home shortly thereafter by the coroner. Given the proximity to the booster, autopsy was requested by coroner and wife consented to this. This is still underway at this time and the body has yet to be released to the funeral home. Of note, patient's spouse reported increased chest discomfort prior to this event and the patient has been battling chronic stable angina for quite some time. The time frame and details of that discomfort were not further examined given the purpose of this call. Additionally, the patient notably developed a ACPA positive polymyalgia rheumatica earlier this year.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Loss of consciousness, Pulse absent, Pyrexia, Resuscitation
Clinical narrative: Narrative:  Patient received an additional booster (she reports 4th dose, Pfizer, however this, nor the alluded to 3rd dose, was not received at agency MC) on 12/29/21. That evening, he began to feel poorly and they noted tachycardia, hypertension, fevers, and chills. This prompted a call to the agency nurses line which is documented 12/30/21. Unfortunately, during that call, his wife reports that he had a "seizure" and lost consciousness. She called EMS at that time, and states she performed some chest compressions as the paramedics were on their way. Patient was pulseless upon their arrival and declared dead at home shortly thereafter by the coroner. Given the proximity to the booster, autopsy was requested by coroner and wife consented to this. This is still underway at this time and the body has yet to be released to the funeral home. Of note, patient's spouse reported increased chest discomfort prior to this event and the patient has been battling chronic stable angina for quite some time. The time frame and details of that discomfort were not further examined given the purpose of this call. Additionally, the patient notably developed a ACPA positive polymyalgia rheumatica earlier this year.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure, Tachycardia
Clinical narrative: Narrative:  Patient received an additional booster (she reports 4th dose, Pfizer, however this, nor the alluded to 3rd dose, was not received at agency MC) on 12/29/21. That evening, he began to feel poorly and they noted tachycardia, hypertension, fevers, and chills. This prompted a call to the agency nurses line which is documented 12/30/21. Unfortunately, during that call, his wife reports that he had a "seizure" and lost consciousness. She called EMS at that time, and states she performed some chest compressions as the paramedics were on their way. Patient was pulseless upon their arrival and declared dead at home shortly thereafter by the coroner. Given the proximity to the booster, autopsy was requested by coroner and wife consented to this. This is still underway at this time and the body has yet to be released to the funeral home. Of note, patient's spouse reported increased chest discomfort prior to this event and the patient has been battling chronic stable angina for quite some time. The time frame and details of that discomfort were not further examined given the purpose of this call. Additionally, the patient notably developed a ACPA positive polymyalgia rheumatica earlier this year.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dyspnoea, Exposure to SARS-CoV-2, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 10/14, Pfizer, dose #3 12/22 COVID swab, result: detected 12/22 SARS-COV-2 Variant Sequencing: pending 12/21 pt cc: chills, sore throat, rhinorrhea, dyspnea, congestion & sneezing exposure wife 12/28 clinically resolved
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 10/14, Pfizer, dose #3 12/22 COVID swab, result: detected 12/22 SARS-COV-2 Variant Sequencing: pending 12/21 pt cc: chills, sore throat, rhinorrhea, dyspnea, congestion & sneezing exposure wife 12/28 clinically resolved
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 07/09 COVID swab, result: not detected 12/22 COVID swab, result: detected 12/22 pt cc: cold symptoms exposure: unknown 2/22 pt admit ED cc: cold symptoms dx: COVID 19 LOS: 1 day 12/22 SARS-COV-2 Variant Sequencing: pending
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/08, Pfizer, dose #1 03/27, Pfizer, dose #2 12/22 COVID swab, result: detected 12/22 SARS-COV-2 Variant Sequencing: pending 12/22 pt cc: exposure: unknown
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Myalgia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/08, Pfizer, dose #1 03/29, Pfizer, dose #2 12/22 COVID swab, result: detected 12/20 pt cc: myalgias, rhinorrhea, cough exposure: unknown
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Cough, Diarrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series Refuses all COVID-19 vaccines (current and future) 12/20 COVID swab, result: detected 12/20 SARS-COV-2 Variant Sequencing: pending 12/20 CXR IMPRESSION: No acute cardiopulmonary disease. 12/18 pt cc: cough, rhinorrhea, fatigue, headache, nausea, congestion, diarrhea, chills exposure: unknown 12/31 clinically resolved
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Refusal of vaccination, Respiratory tract congestion
Clinical narrative: Narrative:  COVID infection following COVID vaccine series Refuses all COVID-19 vaccines (current and future) 12/20 COVID swab, result: detected 12/20 SARS-COV-2 Variant Sequencing: pending 12/20 CXR IMPRESSION: No acute cardiopulmonary disease. 12/18 pt cc: cough, rhinorrhea, fatigue, headache, nausea, congestion, diarrhea, chills exposure: unknown 12/31 clinically resolved
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series Refuses all COVID-19 vaccines (current and future) 12/20 COVID swab, result: detected 12/20 SARS-COV-2 Variant Sequencing: pending 12/20 CXR IMPRESSION: No acute cardiopulmonary disease. 12/18 pt cc: cough, rhinorrhea, fatigue, headache, nausea, congestion, diarrhea, chills exposure: unknown 12/31 clinically resolved
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Choking, Pharyngeal swelling, Throat irritation
Clinical narrative: My throat was itchy at first and then it felt like my throat was closing and at first the pharmacist gave me Benadryl (pill form) and observed me but I still felt like I was choking and eventually I couldn?t speak, and then the pharmacist administered an epi pen.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: Mild fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Mild fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A, 032F21A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Blood pressure high and Hypercholesteraemia.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Mild fever). At the time of the report, PYREXIA (Mild fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: high (High) High. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2021-025459 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Injection site movement impairment, Pain in extremity
Clinical narrative: severe pain where she couldn't even move her arm; severe pain where she couldn't even move her arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), INJECTION SITE MOVEMENT IMPAIRMENT (non-serious) all with onset Mar2021, outcome "not recovered" and all described as "severe pain where she couldn't even move her arm".  Additional Information: The reporter reported that, patient's injection was given extremely high up on her shoulder. Almost on the top of her shoulder. Right after, patient experienced pain, and a few days after, and severe pain where patient couldn't even move her arm. Patient was still in pain today, 19Mar2021. Patient may be hit in the joint or bursa of her shoulder. Patient wanted to know was the vaccine still effective if she wasn't properly vaccinated in the muscle. If the vaccine was administered in the joint, was this a lifelong process or will they resolve on its own.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Muscle tightness, Muscle twitching, Myalgia
Clinical narrative: muscle twitches and spasms around my mouth intermittent; muscle twitches and spasms around my mouth intermittent; muscle tightness across my mouth and cheeks; muscles in the cheek were sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021258083 (Pfizer).  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 05Mar2021 18:30 (Batch/Lot number: unknown) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hypertension" (unspecified if ongoing). Concomitant medication(s) included: MAXZIDE; METOPROLOL TARTRATE taken for hypertension; VITAMIN C ASC ACID. The following information was reported: MUSCLE TWITCHING (non-serious), MUSCLE SPASMS (non-serious) all with onset 06Mar2021 11:00, outcome "not recovered" and all described as "muscle twitches and spasms around my mouth intermittent"; MUSCLE TIGHTNESS (non-serious) with onset 06Mar2021 11:00, outcome "not recovered", described as "muscle tightness across my mouth and cheeks"; MYALGIA (non-serious) with onset 06Mar2021 11:00, outcome "not recovered", described as "muscles in the cheek were sore". Therapeutic measures were not taken as a result of muscle twitching, muscle spasms, muscle tightness, myalgia.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Head discomfort
Clinical narrative: I am very functional but head feels weird during the day/I have brain fog and weird feelings in brain; Head is messed up; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021273044.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 14:45 (Lot number: EN6203) at the age of 66 years as 1st dose, single for covid-19 immunisation. Relevant medical history included: "Known_allergies: Latex" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEAD DISCOMFORT (non-serious) with onset 03Mar2021, outcome "not recovered", described as "Head is messed up"; FEELING ABNORMAL (non-serious) with onset 04Mar2021, outcome "not recovered", described as "I am very functional but head feels weird during the day/I have brain fog and weird feelings in brain". Therapeutic measures were not taken as a result of head discomfort, feeling abnormal. Additional information: Facility where the most recent COVID-19 vaccine was administered reported as Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnose with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Movement disorder, Pain, Pyrexia
Clinical narrative: Chills; body aches; Body aches made movement difficult; Temp not taken but felt like had fever; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 immunisation. The following information was reported: CHILLS (non-serious), outcome "recovered", described as "Chills"; PAIN (non-serious), outcome "recovered", described as "body aches"; MOVEMENT DISORDER (non-serious), outcome "unknown", described as "Body aches made movement difficult"; PYREXIA (non-serious), outcome "unknown", described as "Temp not taken but felt like had fever". Additional information: The events chills and body aches started hours after 2nd shot given at 10 am and began to resolve by 10 am the next morning. Events took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Breakthrough case / covid test result=Positive; Breakthrough case / covid test result=Positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  An 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Feb2021 (Lot number: EL3247) at the age of 29 years as dose 2, single, and administration date 26Jan2021 (Lot number: El3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 28Dec2021, outcome recovering. The patient underwent the following laboratory tests and procedures sars-cov-2 test (28Dec2021) positive, Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19. No, covid prior vaccination. No known allergies.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pigmentation disorder
Clinical narrative: Circle under right arm; got #1 covax today, 01Feb and second covax scheduled 4 weeks later 01Mar; This is a spontaneous report from a contactable consumer (Patient). This consumer reported via medical information team. A 71-year-old female received (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL1283), via unspecified route, administered in arm right on 01Feb2021(Age at the vaccination 71-years-old), as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 10Feb2021, patient got #1 covax today, 01Feb and second covax scheduled 4 weeks later 01Mar. On 13Feb2021, the patient experienced Circle under right arm. As a result of the event patient went to physician office. Outcome of the event was not recovered at the time of reporting.  Follow-up (09Mar2021): New information from a contactable consumer. This 71-year-old female consumer reported in response to Non-HCP letter sent that included: New event (Circle under right arm), age at the vaccination 71 years old, Height and weigh captured.   Follow-up (10May2021): Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: minor fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 08Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "minor fatigue".  Additional information: The report was received from a Pfizer-sponsored program.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021285292 Same reporter, suspect product and events; different patient
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: I notified you after 2nd, I dizziness that lasted everyday for 4 months; vertigo; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200009216 (Pfizer).  A 69 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 24Mar2021 12:00 (Lot number: en6199) at the age of 69 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "ibs" (unspecified if ongoing); "Lower back problems" (unspecified if ongoing), notes: Verbatim:Lower back problems; "Penicillin" (unspecified if ongoing); "Sulf" (unspecified if ongoing). Concomitant medication(s) included: CLONAZEPAM; AMLODIPINE; ENALAPRIL; NORTRIPTYLINE. Past drug history included: Tetracycline, reaction(s): "Allergy_Tetracycline". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER2613, vaccine location=Right arm), administration date: 03Mar2021, for Covid-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset 24Mar2021 12:45, outcome "recovered" (2021), described as "I notified you after 2nd, I dizziness that lasted everyday for 4 months"; VERTIGO (non-serious) with onset 2021, outcome "unknown", described as "vertigo". The event "i notified you after 2nd, i dizziness that lasted everyday for 4 months" was evaluated at the physician office visit. Therapeutic measures were taken as a result of dizziness, vertigo.  Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.Treatment received for the adverse event was vertigo medicine, Prior to vaccination, the patient had not diagnosed with COVID-19.Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall, Loss of consciousness, SARS-CoV-2 test, Tinnitus
Clinical narrative: collapsed onto the floor at work; collapsed onto the floor at work; vertigo; dizzy; tinnitus; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.   A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 19Feb2021 09:00 (Lot number: EL9269) at the age of 49 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Ulcerative Colitis" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "Meniere's Disease" (unspecified if ongoing). Concomitant medication included: HUMIRA (ongoing); LISINOPRIL; HYDROCHLOROTHIAZIDE; PRAVASTATIN. Past drug history included: Known allergies=ampicillian, reaction(s): "known allergies=ampicillian", notes: known allergies=ampicillian. The following information was reported: LOSS OF CONSCIOUSNESS (non-serious), FALL (non-serious) all with onset 09Mar2021 10:00, outcome "recovered with sequelae" and all described as "collapsed onto the floor at work"; VERTIGO (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "vertigo"; VERTIGO (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "I spun my head it felt like it did not stop but kept going"; DIZZINESS (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "dizzy"; TINNITUS (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "ears were roaring with tinnitus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Jun2021) negative, notes: Nasal Swab; (18Dec2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of loss of consciousness, fall, vertigo, vertigo, dizziness, tinnitus. Clinical course: Beginning 18 days after the first dose on 09Mar2021, patient suddenly encountered vertigo. When he spun his head, it felt like it did not stop but kept going and he collapsed onto the floor at work. He needed to sit down the rest of the day. The next morning, he was very dizzy, and his ears were roaring with tinnitus when the rooms ambient sound was quiet. It slowly went away over a three-week period. He called his gastroenterologist because he had assumed it was the Humira he had started 6 weeks earlier, but he said Humira has no such side effects. He continued to take the Humira with no effects. He later heard about vertigo and tinnitus being reported as side effects from the vaccine.   No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: collapsed onto the floor at work; collapsed onto the floor at work; vertigo; dizzy; tinnitus; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.   A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 19Feb2021 09:00 (Lot number: EL9269) at the age of 49 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Ulcerative Colitis" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "Meniere's Disease" (unspecified if ongoing). Concomitant medication included: HUMIRA (ongoing); LISINOPRIL; HYDROCHLOROTHIAZIDE; PRAVASTATIN. Past drug history included: Known allergies=ampicillian, reaction(s): "known allergies=ampicillian", notes: known allergies=ampicillian. The following information was reported: LOSS OF CONSCIOUSNESS (non-serious), FALL (non-serious) all with onset 09Mar2021 10:00, outcome "recovered with sequelae" and all described as "collapsed onto the floor at work"; VERTIGO (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "vertigo"; VERTIGO (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "I spun my head it felt like it did not stop but kept going"; DIZZINESS (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "dizzy"; TINNITUS (non-serious) with onset 09Mar2021 10:00, outcome "recovered with sequelae", described as "ears were roaring with tinnitus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Jun2021) negative, notes: Nasal Swab; (18Dec2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of loss of consciousness, fall, vertigo, vertigo, dizziness, tinnitus. Clinical course: Beginning 18 days after the first dose on 09Mar2021, patient suddenly encountered vertigo. When he spun his head, it felt like it did not stop but kept going and he collapsed onto the floor at work. He needed to sit down the rest of the day. The next morning, he was very dizzy, and his ears were roaring with tinnitus when the rooms ambient sound was quiet. It slowly went away over a three-week period. He called his gastroenterologist because he had assumed it was the Humira he had started 6 weeks earlier, but he said Humira has no such side effects. He continued to take the Humira with no effects. He later heard about vertigo and tinnitus being reported as side effects from the vaccine.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Catheterisation cardiac abnormal, Chest discomfort, Chest pain, Computerised tomogram
Clinical narrative: entering office felt shortness of breath and tightness in chest that increased with pain. Within 5 hours I received a heart catherization post MRI with contrast, CT arth, EKG, Ultrasound.  Catherization was performed by Dr who found a 99.8 percent blockage of Right ascending coronary artery with multiple clots all over the right side of the heart within the tributary arteries. Dr at the time of finding clots said to me "what on earth did you do that past couple days that was physically strenuous. My response was nothing out of ordinary except work, 45 min row with a 1 mile warm up jog. I said its been ground hog day with COVID and do pretty much the same each day. " his response was no way, you had to do something to cause this many clots" My response "the only thing exciting I have done new in the last 6 months was get a Covid injection. He asked which one and I told him J & J and he said Covid causes clots and there have been reports of increased clots within study"
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery occlusion, Dyspnoea, Echocardiogram, Electrocardiogram, Intracardiac thrombus
Clinical narrative: entering office felt shortness of breath and tightness in chest that increased with pain. Within 5 hours I received a heart catherization post MRI with contrast, CT arth, EKG, Ultrasound.  Catherization was performed by Dr who found a 99.8 percent blockage of Right ascending coronary artery with multiple clots all over the right side of the heart within the tributary arteries. Dr at the time of finding clots said to me "what on earth did you do that past couple days that was physically strenuous. My response was nothing out of ordinary except work, 45 min row with a 1 mile warm up jog. I said its been ground hog day with COVID and do pretty much the same each day. " his response was no way, you had to do something to cause this many clots" My response "the only thing exciting I have done new in the last 6 months was get a Covid injection. He asked which one and I told him J & J and he said Covid causes clots and there have been reports of increased clots within study"
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging heart, Scan with contrast, Ultrasound scan
Clinical narrative: entering office felt shortness of breath and tightness in chest that increased with pain. Within 5 hours I received a heart catherization post MRI with contrast, CT arth, EKG, Ultrasound.  Catherization was performed by Dr who found a 99.8 percent blockage of Right ascending coronary artery with multiple clots all over the right side of the heart within the tributary arteries. Dr at the time of finding clots said to me "what on earth did you do that past couple days that was physically strenuous. My response was nothing out of ordinary except work, 45 min row with a 1 mile warm up jog. I said its been ground hog day with COVID and do pretty much the same each day. " his response was no way, you had to do something to cause this many clots" My response "the only thing exciting I have done new in the last 6 months was get a Covid injection. He asked which one and I told him J & J and he said Covid causes clots and there have been reports of increased clots within study"
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Pharyngeal swelling
Clinical narrative: Soreness in the left side of neck; Swelling in throat; This is a spontaneous report from a contactable consumer, the patient. A  34-year-old male patient  received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 18:00 (at the age of 34-year-old), as a single dose for COVID-19 immunisation. Patient had no relevant medical history. The patient never had a previous allergic reaction to any shot, medication, or food. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021, (approximately 5 minutes after the shot), the patient experienced swelling in his throat. The swelling did not restrict his breathing but it was uncomfortable and unlike anything he had experience before; On the same day 15Apr2021 06:15 PM (within a few minutes of getting the vaccine shot in left arm), the patient experienced soreness in the left side of his neck. Approximately 10 minutes after the symptoms began, the swelling of his throat went away. The clinical outcome of the event of throat swelling was recovered  on 15Apr2021 while the clinical outcome of the event of neck pain  was unknown at  time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: To amend State deleted in general and patient tab; Event Neck pain start time updated; Treatment received updated.